WASHINGTON – The Consumer Healthcare Products Association’s (CHPA) 2021 Regulatory, Scientific, and Quality (RSQ) Conference, held virtually last week, included a dietary supplement track with panels on emerging trends and issues for the category. The conference featured record participation from the U.S. Food and Drug Administration (FDA), including Acting Commissioner Dr. Janet Woodcock and Acting
WASHINGTON— Dr. Janet Woodcock, who has led the Food and Drug Administration’s drug review efforts for years, has been tapped to lead the agency on an interim basis after current Commissioner Stephen Hahn leaves office today. President-elect Joe Biden has yet to nominate an FDA commissioner. Dr. Hahn has designated Dr. Woodcock as interim commissioner
MOUNT PROSPECT, Ill. — The National Association of Boards of Pharmacy (NABP) announced it has been awarded funding from Food and Drug Administration (FDA) to create a data system to assist with the collection of critical information to protect public health. The new system will enable the collection, management, and sharing of information regarding compounding
WASHINGTON — Facing a national shortage of EpiPens, the Food and Drug Administration has extended the expiration dates of certain lots of the life-saving allergy drug by four months. The extensions apply to the 0.3 mg dose of EpiPen and its authorized generic, with current expiration dates between April and December 2018, according to a statement
